Your Article Summary
Human African trypanosomiasis, chemotherapy and CNS disease
Journal of Neuroimmunology, 06/25/09
Rodgers J - This review summarises the clinical manifestations of the infection and chemotherapeutic regimens as well as the current research findings and hypotheses regarding the neuropathogenesis of the disease.
Related Articles
Human African trypanosomiasis
The Lancet - Early Online Publication, 10/14/09
Relevance Score: 79%
Cerebrospinal fluid B lymphocyte identification for diagnosis and follow-up in human African trypanosomiasis in the field
Tropical Medicine & International Health, 10/08/09
Relevance Score: 79%
Racial differences in abdominal depot–specific adiposity in white and African American adults
American Journal of Clinical Nutrition, 10/27/09
Relevance Score: 65%
Is the Recommended Dose of Efavirenz Optimal in Young West African Human Immunodeficiency Virus-Infected Children
Antimicrobial Agents and Chemotherapy, 10/08/09
Relevance Score: 64%
NFKBIZ polymorphisms and susceptibility to pneumococcal disease in European and African populations
Genes and Immunity, 10/06/09
Relevance Score: 64%
Today in CNS Infectious Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
A replication study of the association between the IL12B promoter allele CTCTAA and susceptibility to cerebral malaria in Thai population
Malaria Journal, 12/11/09
Intraventricular fungus ball: a unique manifestation of refractory intracranial candidiasis in an immunocompetent neonate
Journal of Neurosurgery: Pediatrics, 12/11/09
Tigecycline use in two cases with multidrug-resistant Acinetobacter baumannii meningitis
International Journal of Infectious Diseases, 12/07/09

See Latest Articles